Skip to main content
. 2019 Aug 9;98(32):e16490. doi: 10.1097/MD.0000000000016490

Figure 4.

Figure 4

The serum tumor marker levels of carbohydrate antigen 199 and carbohydrate antigen 125. After nivolumab combined with chemotherapy is administered, the serum tumor marker level continues to reduce. Nivolumab was administered (green arrows); nivolumab combined with S1 was given (red arrows); nivolumab combined with SOX was given (blue arrows).